Cytokine Dysregulation in Aged Horses and Horses with Pituitary Pars Intermedia Dysfunction
Background: Equine pituitary pars intermedia dysfunction (PPID) is the result of a loss of dopaminergic inhibition of the pars intermedia secondary to neurodegeneration of periventricular hypothalamic neurons. The pathologic events contributing to development of neurodegeneration or clinical signs i...
Saved in:
Published in | Journal of veterinary internal medicine Vol. 22; no. 2; pp. 436 - 442 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Malden, USA
Blackwell Publishing Inc
01.03.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background: Equine pituitary pars intermedia dysfunction (PPID) is the result of a loss of dopaminergic inhibition of the pars intermedia secondary to neurodegeneration of periventricular hypothalamic neurons. The pathologic events contributing to development of neurodegeneration or clinical signs in equids with PPID are unknown. Chronic inflammation may contribute to initiation or progression of PPID.
Hypothesis: Horses with PPID have a distinct systemic cytokine profile compared with that of normal adult or aged horses. The cytokine profile of healthy aged horses differs from that of adult horses.
Animals: Aged horses with PPID, healthy aged‐matched controls, and adult controls (n = 14 per group).
Methods: Total leukocyte cytokine expression was determined by quantitative polymerase chain reaction (PCR), and tumor necrosis factor (TNF)‐α plasma concentration was determined by enzyme‐linked immunosorbent assay (ELISA). Peripheral blood mononuclear cell (PBMC) TNF‐α response after endotoxin (lipopolysaccharide [LPS]) treatment was assessed by ELISA.
Results: Aged healthy horses had increased expression of interleukin (IL)‐6, IL‐8, and interferon‐γ as well as PBMC TNF‐α release after LPS stimulation compared with healthy adult horses. In contrast, aged horses with PPID had increased IL‐8 expression, but expression of other cytokines was similar to that of healthy adult horses, not age‐matched controls.
Conclusions and Clinical Importance: Aged horses show evidence of a proinflammatory state that may contribute to development of age‐associated diseases. Horses with PPID have increased expression of IL‐8, which may influence the ability of horses with PPID to respond to bacterial pathogens. The general decrease in proinflammatory cytokine expression observed in horses with PPID may be the outcome of high plasma concentrations of anti‐inflammatory hormones. |
---|---|
AbstractList | Background: Equine pituitary pars intermedia dysfunction (PPID) is the result of a loss of dopaminergic inhibition of the pars intermedia secondary to neurodegeneration of periventricular hypothalamic neurons. The pathologic events contributing to development of neurodegeneration or clinical signs in equids with PPID are unknown. Chronic inflammation may contribute to initiation or progression of PPID. Hypothesis: Horses with PPID have a distinct systemic cytokine profile compared with that of normal adult or aged horses. The cytokine profile of healthy aged horses differs from that of adult horses. Animals: Aged horses with PPID, healthy aged-matched controls, and adult controls (n = 14 per group). Methods: Total leukocyte cytokine expression was determined by quantitative polymerase chain reaction (PCR), and tumor necrosis factor (TNF)-a plasma concentration was determined by enzyme-linked immunosorbent assay (ELISA). Peripheral blood mononuclear cell (PBMC) TNF-a response after endotoxin (lipopolysaccharide [LPS]) treatment was assessed by ELISA. Results: Aged healthy horses had increased expression of interleukin (IL)-6, IL-8, and interferon-g as well as PBMC TNF-a release after LPS stimulation compared with healthy adult horses. In contrast, aged horses with PPID had increased IL-8 expression, but expression of other cytokines was similar to that of healthy adult horses, not age-matched controls. Conclusions and Clinical Importance: Aged horses show evidence of a proinflammatory state that may contribute to development of age-associated diseases. Horses with PPID have increased expression of IL-8, which may influence the ability of horses with PPID to respond to bacterial pathogens. The general decrease in proinflammatory cytokine expression observed in horses with PPID may be the outcome of high plasma concentrations of anti-inflammatory hormones. Submitted June 27, 2007; Revised October 5, 2007; Accepted November 19, 2007. Background: Equine pituitary pars intermedia dysfunction (PPID) is the result of a loss of dopaminergic inhibition of the pars intermedia secondary to neurodegeneration of periventricular hypothalamic neurons. The pathologic events contributing to development of neurodegeneration or clinical signs in equids with PPID are unknown. Chronic inflammation may contribute to initiation or progression of PPID. Hypothesis: Horses with PPID have a distinct systemic cytokine profile compared with that of normal adult or aged horses. The cytokine profile of healthy aged horses differs from that of adult horses. Animals: Aged horses with PPID, healthy aged‐matched controls, and adult controls (n = 14 per group). Methods: Total leukocyte cytokine expression was determined by quantitative polymerase chain reaction (PCR), and tumor necrosis factor (TNF)‐α plasma concentration was determined by enzyme‐linked immunosorbent assay (ELISA). Peripheral blood mononuclear cell (PBMC) TNF‐α response after endotoxin (lipopolysaccharide [LPS]) treatment was assessed by ELISA. Results: Aged healthy horses had increased expression of interleukin (IL)‐6, IL‐8, and interferon‐γ as well as PBMC TNF‐α release after LPS stimulation compared with healthy adult horses. In contrast, aged horses with PPID had increased IL‐8 expression, but expression of other cytokines was similar to that of healthy adult horses, not age‐matched controls. Conclusions and Clinical Importance: Aged horses show evidence of a proinflammatory state that may contribute to development of age‐associated diseases. Horses with PPID have increased expression of IL‐8, which may influence the ability of horses with PPID to respond to bacterial pathogens. The general decrease in proinflammatory cytokine expression observed in horses with PPID may be the outcome of high plasma concentrations of anti‐inflammatory hormones. Equine pituitary pars intermedia dysfunction (PPID) is the result of a loss of dopaminergic inhibition of the pars intermedia secondary to neurodegeneration of periventricular hypothalamic neurons. The pathologic events contributing to development of neurodegeneration or clinical signs in equids with PPID are unknown. Chronic inflammation may contribute to initiation or progression of PPID. Horses with PPID have a distinct systemic cytokine profile compared with that of normal adult or aged horses. The cytokine profile of healthy aged horses differs from that of adult horses. Aged horses with PPID, healthy aged-matched controls, and adult controls (n = 14 per group). Total leukocyte cytokine expression was determined by quantitative polymerase chain reaction (PCR), and tumor necrosis factor (TNF)-alpha plasma concentration was determined by enzyme-linked immunosorbent assay (ELISA). Peripheral blood mononuclear cell (PBMC) TNF-alpha response after endotoxin (lipopolysaccharide [LPS]) treatment was assessed by ELISA. Aged healthy horses had increased expression of interleukin (IL)-6, IL-8, and interferon-gamma as well as PBMC TNF-alpha release after LPS stimulation compared with healthy adult horses. In contrast, aged horses with PPID had increased IL-8 expression, but expression of other cytokines was similar to that of healthy adult horses, not age-matched controls. Aged horses show evidence of a proinflammatory state that may contribute to development of age-associated diseases. Horses with PPID have increased expression of IL-8, which may influence the ability of horses with PPID to respond to bacterial pathogens. The general decrease in proinflammatory cytokine expression observed in horses with PPID may be the outcome of high plasma concentrations of anti-inflammatory hormones. BACKGROUNDEquine pituitary pars intermedia dysfunction (PPID) is the result of a loss of dopaminergic inhibition of the pars intermedia secondary to neurodegeneration of periventricular hypothalamic neurons. The pathologic events contributing to development of neurodegeneration or clinical signs in equids with PPID are unknown. Chronic inflammation may contribute to initiation or progression of PPID.HYPOTHESISHorses with PPID have a distinct systemic cytokine profile compared with that of normal adult or aged horses. The cytokine profile of healthy aged horses differs from that of adult horses.ANIMALSAged horses with PPID, healthy aged-matched controls, and adult controls (n = 14 per group).METHODSTotal leukocyte cytokine expression was determined by quantitative polymerase chain reaction (PCR), and tumor necrosis factor (TNF)-alpha plasma concentration was determined by enzyme-linked immunosorbent assay (ELISA). Peripheral blood mononuclear cell (PBMC) TNF-alpha response after endotoxin (lipopolysaccharide [LPS]) treatment was assessed by ELISA.RESULTSAged healthy horses had increased expression of interleukin (IL)-6, IL-8, and interferon-gamma as well as PBMC TNF-alpha release after LPS stimulation compared with healthy adult horses. In contrast, aged horses with PPID had increased IL-8 expression, but expression of other cytokines was similar to that of healthy adult horses, not age-matched controls.CONCLUSIONS AND CLINICAL IMPORTANCEAged horses show evidence of a proinflammatory state that may contribute to development of age-associated diseases. Horses with PPID have increased expression of IL-8, which may influence the ability of horses with PPID to respond to bacterial pathogens. The general decrease in proinflammatory cytokine expression observed in horses with PPID may be the outcome of high plasma concentrations of anti-inflammatory hormones. Background: Equine pituitary pars intermedia dysfunction (PPID) is the result of a loss of dopaminergic inhibition of the pars intermedia secondary to neurodegeneration of periventricular hypothalamic neurons. The pathologic events contributing to development of neurodegeneration or clinical signs in equids with PPID are unknown. Chronic inflammation may contribute to initiation or progression of PPID. Hypothesis: Horses with PPID have a distinct systemic cytokine profile compared with that of normal adult or aged horses. The cytokine profile of healthy aged horses differs from that of adult horses. Animals: Aged horses with PPID, healthy aged‐matched controls, and adult controls (n = 14 per group). Methods: Total leukocyte cytokine expression was determined by quantitative polymerase chain reaction (PCR), and tumor necrosis factor (TNF)‐α plasma concentration was determined by enzyme‐linked immunosorbent assay (ELISA). Peripheral blood mononuclear cell (PBMC) TNF‐α response after endotoxin (lipopolysaccharide [LPS]) treatment was assessed by ELISA. Results: Aged healthy horses had increased expression of interleukin (IL)‐6, IL‐8, and interferon‐γ as well as PBMC TNF‐α release after LPS stimulation compared with healthy adult horses. In contrast, aged horses with PPID had increased IL‐8 expression, but expression of other cytokines was similar to that of healthy adult horses, not age‐matched controls. Conclusions and Clinical Importance: Aged horses show evidence of a proinflammatory state that may contribute to development of age‐associated diseases. Horses with PPID have increased expression of IL‐8, which may influence the ability of horses with PPID to respond to bacterial pathogens. The general decrease in proinflammatory cytokine expression observed in horses with PPID may be the outcome of high plasma concentrations of anti‐inflammatory hormones. |
Author | Holbrook, T.C. McFarlane, D. |
Author_xml | – sequence: 1 fullname: McFarlane, D – sequence: 2 fullname: Holbrook, T.C |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18371032$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkk9v0zAYxi20iXUbX4HlBKcU_4ntRJymAm3ZxiaxwYHDKye2i7s0GXaitd8eR6m6G8IXv7J-z2P5eXyKjpq2MQhdEDwlcX1YT0nBipQIKaYU43yKcZy2r9DkcH6EJjgvSCpEhk_QaQhrjCnnXL5GJyRnkmBGJ-jXbNe1j64xyadd8GbV16pzbZO4JrlcGZ0sWh9MSFRzGJ9d9zu5c13vOuV3yZ3yIVk2nfEbo50abGzfVIPJOTq2qg7mzX4_Qw9fPt_PFun17Xw5u7xOK46FSKnOi0wSK0rFRUUYVcYWXJe5LVhmGLa6MKUg0pa5pJwqYbW2pZTUaqvLkrEz9H70ffLtn96EDjYuVKauVWPaPkCBKWOckiyS7_5JSpxxwngeQTmClW9DzMXCk3eb-F4gGIYGYA1D0jAkDUMDMDQA26h8u7-iL2MiL7p95BH4OALPrja7__WFrz-WN1JEdTqqXejM9qBW_hGEZJLDz29z4Iurq_n9DYVZ5C9G3qoW1Mq7AA_fKSYsWuc8fhD2F-UFr4A |
CitedBy_id | crossref_primary_10_1016_j_tvjl_2011_03_021 crossref_primary_10_1111_j_1751_0813_2010_00637_x crossref_primary_10_1016_j_vetimm_2010_06_018 crossref_primary_10_1016_j_domaniend_2014_07_003 crossref_primary_10_2460_javma_243_12_1762 crossref_primary_10_1007_s12015_015_9638_0 crossref_primary_10_1016_j_domaniend_2020_106531 crossref_primary_10_1016_j_jevs_2010_07_015 crossref_primary_10_1111_evj_12045 crossref_primary_10_2460_ajvr_75_7_658 crossref_primary_10_1186_s12917_016_0742_4 crossref_primary_10_1111_j_1939_1676_2012_01022_x crossref_primary_10_3727_215517912X647217 crossref_primary_10_1016_j_vetimm_2014_02_001 crossref_primary_10_1111_eve_12749 crossref_primary_10_1111_j_2042_3306_2010_00085_x crossref_primary_10_1111_jvim_15302 crossref_primary_10_1016_j_jevs_2013_01_006 crossref_primary_10_1186_s12917_019_2144_x crossref_primary_10_1371_journal_pone_0254139 crossref_primary_10_1186_s12979_022_00325_5 crossref_primary_10_3389_fragi_2021_708918 crossref_primary_10_1089_scd_2013_0537 crossref_primary_10_1111_eve_12237 crossref_primary_10_1016_j_dci_2012_11_007 crossref_primary_10_1016_j_vetimm_2022_110459 crossref_primary_10_2460_javma_241_2_241 crossref_primary_10_1016_j_vetimm_2020_110013 crossref_primary_10_2460_javma_238_10_1305 crossref_primary_10_1016_j_cveq_2016_04_009 crossref_primary_10_1111_j_2042_3306_2010_00092_x crossref_primary_10_1016_j_cveq_2019_03_005 crossref_primary_10_1016_j_domaniend_2020_106476 crossref_primary_10_1016_j_jevs_2023_104879 crossref_primary_10_1016_j_cveq_2010_12_007 crossref_primary_10_1016_j_jevs_2021_103824 crossref_primary_10_3390_vetsci9100556 crossref_primary_10_3390_ani12060744 crossref_primary_10_1111_j_2042_3292_2011_00327_x crossref_primary_10_1016_j_tvjl_2013_07_020 crossref_primary_10_1016_j_jevs_2011_03_056 crossref_primary_10_2527_jas_2015_9634 crossref_primary_10_3389_fvets_2024_1414426 crossref_primary_10_1016_j_prevetmed_2011_06_002 crossref_primary_10_1111_j_2042_3306_2010_00256_x crossref_primary_10_1111_j_2042_3306_2012_00600_x crossref_primary_10_1111_eve_13593 crossref_primary_10_1016_j_jevs_2009_01_004 crossref_primary_10_1002_jor_20933 crossref_primary_10_1111_vop_12817 crossref_primary_10_1016_j_jveb_2015_08_007 crossref_primary_10_3390_cells10051138 crossref_primary_10_1177_0300985815608674 crossref_primary_10_1016_j_vetimm_2015_04_006 |
Cites_doi | 10.1016/j.exger.2006.09.005 10.1210/me.12.8.1133 10.1016/S0047-6374(97)00153-X 10.1016/j.intimp.2004.05.006 10.1002/path.2104 10.1159/000126999 10.1212/WNL.38.8.1285 10.1097/01.jnen.0000202887.22082.63 10.1093/gerona/60.2.195 10.1002/glia.20015 10.1111/j.2042-3292.1992.tb01595.x 10.1111/j.1365-2826.2005.01277.x 10.1016/j.jneuroim.2005.01.008 10.2460/ajvr.2004.65.1701 10.1515/CCLM.2003.136 10.1016/S0531-5565(01)00189-9 10.2460/javma.2003.223.99 10.1111/j.1939-1676.2002.tb02418.x 10.2460/ajvr.2004.65.1463 10.1016/0006-8993(95)01189-7 10.2746/042516402776250333 10.2527/jas.2006-673 |
ContentType | Journal Article |
Copyright | Copyright © 2008 by the American College of Veterinary Internal Medicine |
Copyright_xml | – notice: Copyright © 2008 by the American College of Veterinary Internal Medicine |
DBID | FBQ BSCLL CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 7T5 7TK H94 |
DOI | 10.1111/j.1939-1676.2008.0076.x |
DatabaseName | AGRIS Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic Immunology Abstracts Neurosciences Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic AIDS and Cancer Research Abstracts Neurosciences Abstracts Immunology Abstracts |
DatabaseTitleList | AIDS and Cancer Research Abstracts CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Veterinary Medicine |
EISSN | 1939-1676 |
EndPage | 442 |
ExternalDocumentID | 10_1111_j_1939_1676_2008_0076_x 18371032 JVIM76 ark_67375_WNG_5HKKGTM2_C US201300885089 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | .3N .GA .Y3 05W 0R~ 10A 1OC 24P 29L 31~ 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 8FE 8FH 8FI 8FJ 8UM 930 A03 AAHHS AAONW AAZKR ABCQN ABEML ABPTK ABUWG ACBWZ ACCFJ ACSCC ACXQS ADBBV ADKYN ADRAZ ADZMN AEEZP AENEX AEQDE AEUQT AFBPY AFKRA AFRAH AFZJQ AHEFC AHMBA AI. AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS AOIJS ASPBG AVUZU AVWKF AZBYB AZFZN BAFTC BAWUL BCNDV BDRZF BENPR BFHJK BPHCQ BVXVI BY8 CAG CCPQU COF CS3 D-E D-F DIK DR2 DU5 EBS ECGQY EJD ESX EYRJQ F00 F01 F04 FBQ FEDTE FYUFA G-S G.N GODZA GROUPED_DOAJ H.T H.X HF~ HMCUK HOLLA HVGLF HYE HZ~ IAO IHR IX1 J0M KQ8 LC2 LC3 LH4 LP6 LP7 LW6 M48 MK4 N04 N05 N9A NF~ O9- OK1 OVD P2P P2X P4D PIMPY PQQKQ PROAC Q.N Q11 R.K ROL RPM RX1 SJN SUPJJ TEORI UB1 UKHRP VH1 W8V W99 WIN WQJ WRC XG1 ~IA ~KM ~WT AAHBH ALIPV ALUQN BSCLL ITC OIG CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 7T5 7TK H94 |
ID | FETCH-LOGICAL-c5066-2d89471f6ba56c132aef95db8f934e30fd9eb617fb87252a6fddfb772fdfdbb33 |
IEDL.DBID | M48 |
ISSN | 0891-6640 |
IngestDate | Fri Aug 16 10:21:02 EDT 2024 Fri Aug 16 10:38:19 EDT 2024 Thu Sep 26 18:08:06 EDT 2024 Sat Sep 28 07:55:05 EDT 2024 Sat Aug 24 00:54:10 EDT 2024 Wed Oct 30 10:05:27 EDT 2024 Mon Dec 18 05:21:16 EST 2023 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5066-2d89471f6ba56c132aef95db8f934e30fd9eb617fb87252a6fddfb772fdfdbb33 |
Notes | ark:/67375/WNG-5HKKGTM2-C istex:D23256C38759F635A51C6762523AA75CFF2439A2 ArticleID:JVIM76 Portions of this work were presented at the 25th American College of Veterinary Internal Medicine Forum, June 2007, Seattle, WA. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1939-1676.2008.0076.x |
PMID | 18371032 |
PQID | 70451358 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_902335214 proquest_miscellaneous_70451358 crossref_primary_10_1111_j_1939_1676_2008_0076_x pubmed_primary_18371032 wiley_primary_10_1111_j_1939_1676_2008_0076_x_JVIM76 istex_primary_ark_67375_WNG_5HKKGTM2_C fao_agris_US201300885089 |
PublicationCentury | 2000 |
PublicationDate | March–April 2008 |
PublicationDateYYYYMMDD | 2008-03-01 |
PublicationDate_xml | – month: 03 year: 2008 text: March–April 2008 |
PublicationDecade | 2000 |
PublicationPlace | Malden, USA |
PublicationPlace_xml | – name: Malden, USA – name: United States |
PublicationTitle | Journal of veterinary internal medicine |
PublicationTitleAlternate | J Vet Intern Med |
PublicationYear | 2008 |
Publisher | Blackwell Publishing Inc |
Publisher_xml | – name: Blackwell Publishing Inc |
References | Taylor AW. The immunomodulating neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages. J Neuroimmunol 2005;162:43-50. Van Der Kolk JH, Heinrichs M, Van Amerongen JD, et al. Evaluation of pituitary gland anatomy and histopathologic findings in clinically normal horses and horses and ponies with pituitary pars intermedia adenoma. Am J Vet Res 2004;65:1701-1707. Dauer W, Przedborski S. Parkinson's disease: Mechanisms and models. Neuron 2003;39:889-909. Gabriel P, Cakman I, Rink L. Overproduction of monokines by leukocytes after stimulation with lipopolysaccharide in the elderly. Exp Gerontol 2002;37:235-247. Orth DN, Holscher MA, Wilson MG, et al. Equine Cushing's disease: Plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests. Endocrinol 1982;110:1430-1441. Leng S, Xue QL, Huang Y, et al. Total and differential white blood cell counts and their associations with circulating interleukin-6 levels in community-dwelling older women. J Gerontol A Biol Sci Med Sci 2005;60:195-199. Rink L, Cakman I, Kirchner H. Altered cytokine production in the elderly. Mech Ageing Dev 1998;102:199-209. Van Der Kolk HH, Kalsbeek HC, Van Garderen E, et al. Equine pituitary neoplasia: A clinical report of 21 cases (1990-1992). Vet Rec 1993;133:594-597. Bronstein DM, Perez-Otano I, Sun V, et al. Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures. Brain Res 1995;704:112-116. Kurkowska-Jastrzebska I, Litwin T, Joniec I, et al. Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease. Int Immunopharmacol 2004;4:1307-1318. Jerin A, Pozar-Lukanovic N, Sojar V, et al. Balance of pro- and anti-inflammatory cytokines in liver surgery. Clin Chem Lab Med 2003;41:899-903. D'Acquisto F, Ianaro A. From willow bark to peptides: The ever widening spectrum of NF-kappaB inhibitors. Curr Opin Pharmacol 2006;6:387-392. Millington WR, Dybdal NO, Dawson R Jr, et al. Equine Cushing's disease: Differential regulation of β-endorphin processing in tumors of the intermediate pituitary. Endocrinol 1988;123:1598-1604. McGeer PL, Itagaki S, Boyes BE, et al. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988;38:1285-1291. Gao HM, Jiang J, Wilson B, et al. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: Relevance to Parkinson's disease. J Neurochem 2002;81:1285-1297. Barcia C, Sanchez BA, Fernandez-Villalba E, et al. Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure. Glia 2004;46:402-409. Goudreau JL, Falls WM, Lookingland KJ, et al. Periventricular-hypophysial dopaminergic neurons innervate the intermediate but not the neural lobe of the rat pituitary gland. Neuroendocrinol 1995;62:147-154. Conde JR, Streit WJ. Microglia in the aging brain. J Neuropathol Exp Neurol 2006;65:199-203. Vick MM, Adams AA, Murphy BA, et al. Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse. J Anim Sci 2007;85:1144-1155. Nagatsu T, Sawada M. Inflammatory process in Parkinson's disease: Role for cytokines. Curr Pharm Des 2005;11:999-1016. McFarlane D, Donaldson MT, McDonnell SM, et al. Effects of season and sample handling on measurement of plasma alpha-melanocyte-stimulating hormone concentrations in horses and ponies. Am J Vet Res 2004;65:1463-1468. Saiardi A, Borrelli E. Absence of dopaminergic control on melanotrophs leads to Cushing's-like syndrome in mice. Mol Endocrinol 1998;12:1133-1139. Prior C, Knight RA, Herold M, et al. Pulmonary sarcoidosis: Patterns of cytokine release in vitro. Eur Respir J 1996;9:47-53. McFarlane D, Dybdal N, Donaldson MT, et al. Nitration and increased alpha-synuclein expression associated with dopaminergic neurodegeneration in equine pituitary pars intermedia dysfunction. J Neuroendocrinol 2005;17:73-80. Schott HC. Pituitary pars intermedia dysfunction: Equine Cushing's disease. Vet Clin North Am Equine Pract 2002;18:237-270. Perkins GA, Lamb S, Erb HN, et al. Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing's disease with cyproheptadine or pergolide. Equine Vet J 2002;34:679-685. Eylar EH, Lefranc CE, Yamamura Y, et al. HIV infection and aging: Enhanced interferon- and tumor necrosis factor-alpha production by the CD8+. BMC Immunol 2001;2:10. Pawelec G. Immunity and ageing in man. Exp Gerontol 2006;41:1239-1242. Donaldson MT, LaMonte BJ, Morresey P, et al. Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushing's disease). J Vet Intern Med 2002;16:742-746. Brosnahan MM, Paradis MR. Assessment of clinical characteristics, management practices, and activities of geriatric horses. J Am Vet Med Assoc 2003;223:99-103. Hillyer MH, Taylor FRG, Mair TS, et al. Diagnosis of hyperadrenocorticism in the horse. Equine Vet Educ 1992;4:131-134. Gruver A, Hudson L, Sempowski G. Immunosenescence of ageing. J Pathol 2007;211:144-156. 2004; 65 2002; 16 2002; 37 2002; 18 2002; 34 1988; 38 2004; 46 2004; 4 1988; 123 2006; 6 2003; 39 2002; 81 2005; 60 1995; 62 2007; 211 2006; 41 2005; 162 2001 2000 2006; 65 1995; 704 1982; 110 2001; 2 2007; 85 2003; 223 2005; 17 1998; 102 2003; 41 1998; 12 2005; 11 1996; 9 1992; 4 1993; 133 e_1_2_7_3_2 Rozen S (e_1_2_7_22_2) 2000 e_1_2_7_2_2 e_1_2_7_9_2 e_1_2_7_8_2 e_1_2_7_7_2 e_1_2_7_6_2 e_1_2_7_19_2 Prior C (e_1_2_7_30_2) 1996; 9 e_1_2_7_18_2 Van Der Kolk HH (e_1_2_7_32_2) 1993; 133 Orth DN (e_1_2_7_4_2) 1982; 110 e_1_2_7_16_2 e_1_2_7_15_2 e_1_2_7_13_2 e_1_2_7_11_2 e_1_2_7_10_2 Eylar EH (e_1_2_7_29_2) 2001; 2 Gao HM (e_1_2_7_17_2) 2002; 81 e_1_2_7_26_2 Dauer W (e_1_2_7_12_2) 2003; 39 e_1_2_7_27_2 e_1_2_7_28_2 Millington WR (e_1_2_7_5_2) 1988; 123 Schott HC. (e_1_2_7_31_2) 2002; 18 D'Acquisto F (e_1_2_7_35_2) 2006; 6 e_1_2_7_25_2 e_1_2_7_24_2 e_1_2_7_23_2 Nagatsu T (e_1_2_7_14_2) 2005; 11 e_1_2_7_21_2 e_1_2_7_33_2 e_1_2_7_20_2 e_1_2_7_34_2 |
References_xml | – volume: 38 start-page: 1285 year: 1988 end-page: 1291 article-title: Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains publication-title: Neurology – volume: 46 start-page: 402 year: 2004 end-page: 409 article-title: Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure publication-title: Glia – volume: 16 start-page: 742 year: 2002 end-page: 746 article-title: Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushing's disease) publication-title: J Vet Intern Med – volume: 162 start-page: 43 year: 2005 end-page: 50 article-title: The immunomodulating neuropeptide alpha‐melanocyte‐stimulating hormone (alpha‐MSH) suppresses LPS‐stimulated TLR4 with IRAK‐M in macrophages publication-title: J Neuroimmunol – volume: 60 start-page: 195 year: 2005 end-page: 199 article-title: Total and differential white blood cell counts and their associations with circulating interleukin‐6 levels in community‐dwelling older women publication-title: J Gerontol A Biol Sci Med Sci – volume: 34 start-page: 679 year: 2002 end-page: 685 article-title: Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing's disease with cyproheptadine or pergolide publication-title: Equine Vet J – volume: 65 start-page: 1463 year: 2004 end-page: 1468 article-title: Effects of season and sample handling on measurement of plasma alpha‐melanocyte‐stimulating hormone concentrations in horses and ponies publication-title: Am J Vet Res – volume: 81 start-page: 1285 year: 2002 end-page: 1297 article-title: Microglial activation‐mediated delayed and progressive degeneration of rat nigral dopaminergic neurons publication-title: Relevance to Parkinson's disease – volume: 2 start-page: 10 year: 2001 article-title: HIV infection and aging publication-title: Enhanced interferon- and tumor necrosis factor-alpha production by the CD8+ – volume: 6 start-page: 387 year: 2006 end-page: 392 article-title: From willow bark to peptides publication-title: The ever widening spectrum of NF-kappaB inhibitors – volume: 102 start-page: 199 year: 1998 end-page: 209 article-title: Altered cytokine production in the elderly publication-title: Mech Ageing Dev – volume: 4 start-page: 1307 year: 2004 end-page: 1318 article-title: Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease publication-title: Int Immunopharmacol – volume: 11 start-page: 999 year: 2005 end-page: 1016 article-title: Inflammatory process in Parkinson's disease publication-title: Role for cytokines – volume: 85 start-page: 1144 year: 2007 end-page: 1155 article-title: Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse publication-title: J Anim Sci – volume: 18 start-page: 237 year: 2002 end-page: 270 article-title: Pituitary pars intermedia dysfunction publication-title: Equine Cushing's disease – volume: 12 start-page: 1133 year: 1998 end-page: 1139 article-title: Absence of dopaminergic control on melanotrophs leads to Cushing's‐like syndrome in mice publication-title: Mol Endocrinol – volume: 41 start-page: 899 year: 2003 end-page: 903 article-title: Balance of pro‐ and anti‐inflammatory cytokines in liver surgery publication-title: Clin Chem Lab Med – volume: 65 start-page: 199 year: 2006 end-page: 203 article-title: Microglia in the aging brain publication-title: J Neuropathol Exp Neurol – volume: 223 start-page: 99 year: 2003 end-page: 103 article-title: Assessment of clinical characteristics, management practices, and activities of geriatric horses publication-title: J Am Vet Med Assoc – volume: 39 start-page: 889 year: 2003 end-page: 909 article-title: Parkinson's disease publication-title: Mechanisms and models – volume: 37 start-page: 235 year: 2002 end-page: 247 article-title: Overproduction of monokines by leukocytes after stimulation with lipopolysaccharide in the elderly publication-title: Exp Gerontol – volume: 41 start-page: 1239 year: 2006 end-page: 1242 article-title: Immunity and ageing in man publication-title: Exp Gerontol – volume: 110 start-page: 1430 year: 1982 end-page: 1441 article-title: Equine Cushing's disease publication-title: Plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests – start-page: 22 year: 2001 end-page: 24 – volume: 123 start-page: 1598 year: 1988 end-page: 1604 article-title: Equine Cushing's disease publication-title: Differential regulation of β-endorphin processing in tumors of the intermediate pituitary – volume: 17 start-page: 73 year: 2005 end-page: 80 article-title: Nitration and increased alpha‐synuclein expression associated with dopaminergic neurodegeneration in equine pituitary pars intermedia dysfunction publication-title: J Neuroendocrinol – volume: 62 start-page: 147 year: 1995 end-page: 154 article-title: Periventricular‐hypophysial dopaminergic neurons innervate the intermediate but not the neural lobe of the rat pituitary gland publication-title: Neuroendocrinol – volume: 4 start-page: 131 year: 1992 end-page: 134 article-title: Diagnosis of hyperadrenocorticism in the horse publication-title: Equine Vet Educ – volume: 704 start-page: 112 year: 1995 end-page: 116 article-title: Glia‐dependent neurotoxicity and neuroprotection in mesencephalic cultures publication-title: Brain Res – start-page: 365 year: 2000 end-page: 386 – volume: 65 start-page: 1701 year: 2004 end-page: 1707 article-title: Evaluation of pituitary gland anatomy and histopathologic findings in clinically normal horses and horses and ponies with pituitary pars intermedia adenoma publication-title: Am J Vet Res – volume: 133 start-page: 594 year: 1993 end-page: 597 article-title: Equine pituitary neoplasia publication-title: A clinical report of 21 cases (1990–1992) – volume: 211 start-page: 144 year: 2007 end-page: 156 article-title: Immunosenescence of ageing publication-title: J Pathol – volume: 9 start-page: 47 year: 1996 end-page: 53 article-title: Pulmonary sarcoidosis publication-title: Patterns of cytokine release in vitro – ident: e_1_2_7_24_2 doi: 10.1016/j.exger.2006.09.005 – volume: 9 start-page: 47 year: 1996 ident: e_1_2_7_30_2 article-title: Pulmonary sarcoidosis publication-title: Patterns of cytokine release in vitro contributor: fullname: Prior C – ident: e_1_2_7_11_2 doi: 10.1210/me.12.8.1133 – ident: e_1_2_7_25_2 doi: 10.1016/S0047-6374(97)00153-X – volume: 81 start-page: 1285 year: 2002 ident: e_1_2_7_17_2 article-title: Microglial activation‐mediated delayed and progressive degeneration of rat nigral dopaminergic neurons publication-title: Relevance to Parkinson's disease contributor: fullname: Gao HM – volume: 110 start-page: 1430 year: 1982 ident: e_1_2_7_4_2 article-title: Equine Cushing's disease publication-title: Plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests contributor: fullname: Orth DN – ident: e_1_2_7_18_2 doi: 10.1016/j.intimp.2004.05.006 – ident: e_1_2_7_19_2 doi: 10.1002/path.2104 – volume: 6 start-page: 387 year: 2006 ident: e_1_2_7_35_2 article-title: From willow bark to peptides publication-title: The ever widening spectrum of NF-kappaB inhibitors contributor: fullname: D'Acquisto F – volume: 11 start-page: 999 year: 2005 ident: e_1_2_7_14_2 article-title: Inflammatory process in Parkinson's disease publication-title: Role for cytokines contributor: fullname: Nagatsu T – ident: e_1_2_7_10_2 doi: 10.1159/000126999 – volume: 123 start-page: 1598 year: 1988 ident: e_1_2_7_5_2 article-title: Equine Cushing's disease publication-title: Differential regulation of β-endorphin processing in tumors of the intermediate pituitary contributor: fullname: Millington WR – volume: 18 start-page: 237 year: 2002 ident: e_1_2_7_31_2 article-title: Pituitary pars intermedia dysfunction publication-title: Equine Cushing's disease contributor: fullname: Schott HC. – ident: e_1_2_7_13_2 doi: 10.1212/WNL.38.8.1285 – volume: 39 start-page: 889 year: 2003 ident: e_1_2_7_12_2 article-title: Parkinson's disease publication-title: Mechanisms and models contributor: fullname: Dauer W – ident: e_1_2_7_20_2 doi: 10.1097/01.jnen.0000202887.22082.63 – ident: e_1_2_7_28_2 doi: 10.1093/gerona/60.2.195 – start-page: 365 volume-title: Bioinformatics Methods and Protocols: Methods in Molecular Biology year: 2000 ident: e_1_2_7_22_2 contributor: fullname: Rozen S – volume: 2 start-page: 10 year: 2001 ident: e_1_2_7_29_2 article-title: HIV infection and aging publication-title: Enhanced interferon- and tumor necrosis factor-alpha production by the CD8+ contributor: fullname: Eylar EH – ident: e_1_2_7_15_2 doi: 10.1002/glia.20015 – ident: e_1_2_7_33_2 doi: 10.1111/j.2042-3292.1992.tb01595.x – volume: 133 start-page: 594 year: 1993 ident: e_1_2_7_32_2 article-title: Equine pituitary neoplasia publication-title: A clinical report of 21 cases (1990–1992) contributor: fullname: Van Der Kolk HH – ident: e_1_2_7_9_2 doi: 10.1111/j.1365-2826.2005.01277.x – ident: e_1_2_7_34_2 doi: 10.1016/j.jneuroim.2005.01.008 – ident: e_1_2_7_3_2 doi: 10.2460/ajvr.2004.65.1701 – ident: e_1_2_7_26_2 doi: 10.1515/CCLM.2003.136 – ident: e_1_2_7_27_2 doi: 10.1016/S0531-5565(01)00189-9 – ident: e_1_2_7_2_2 doi: 10.2460/javma.2003.223.99 – ident: e_1_2_7_6_2 doi: 10.1111/j.1939-1676.2002.tb02418.x – ident: e_1_2_7_21_2 doi: 10.2460/ajvr.2004.65.1463 – ident: e_1_2_7_7_2 – ident: e_1_2_7_16_2 doi: 10.1016/0006-8993(95)01189-7 – ident: e_1_2_7_8_2 doi: 10.2746/042516402776250333 – ident: e_1_2_7_23_2 doi: 10.2527/jas.2006-673 |
SSID | ssj0025557 |
Score | 2.173727 |
Snippet | Background: Equine pituitary pars intermedia dysfunction (PPID) is the result of a loss of dopaminergic inhibition of the pars intermedia secondary to... Equine pituitary pars intermedia dysfunction (PPID) is the result of a loss of dopaminergic inhibition of the pars intermedia secondary to neurodegeneration of... Background: Equine pituitary pars intermedia dysfunction (PPID) is the result of a loss of dopaminergic inhibition of the pars intermedia secondary to... BACKGROUNDEquine pituitary pars intermedia dysfunction (PPID) is the result of a loss of dopaminergic inhibition of the pars intermedia secondary to... |
SourceID | proquest crossref pubmed wiley istex fao |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 436 |
SubjectTerms | age Aging - physiology Animals Cushing syndrome cytokines Cytokines - genetics Cytokines - metabolism endocrine diseases Equine Cushing's disease Gene Expression Regulation Geriatric Horse Diseases - metabolism Horses Inflammation Pituitary Diseases - metabolism Pituitary Diseases - physiopathology Pituitary Diseases - veterinary Pituitary Gland - physiopathology Pituitary Gland, Intermediate - metabolism Pituitary Gland, Intermediate - physiopathology RNA, Messenger - metabolism Tumor Necrosis Factor-alpha - blood Tumor Necrosis Factor-alpha - metabolism |
SummonAdditionalLinks | – databaseName: Wiley Open Access dbid: 24P link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZteumltOkj7lOH0ptBfkiWjmHbZJuwYaHZNNCDkCxpWQJ2SbyQ_PvOyNptF1Iovelgj22NR_pm9OkTIR9RFI05CEDGg8zrthBIApC5q3xTM2laFwtuszMxXdQnl_wySQrhXphRH2JbcMPIiOM1BrixN7tBriqVF6IRG0oktABOPkL9GJTRL-v5NvfiPIl-qiIXomaJ6pVIPfcZ2pmoHgbTA3zFnr-9D4vuQts4Nx09JU8SqKSH41_wjDzw3T7Zv0CmS9xuS2dpBf05-TG5G_oraNLPd_DQZTq9i646erj0jk57JHVQ022bWKml89WwXg1oag6ZMI11xLjpBM3g3IhGXpDF0ZfzyTRPByzkLQeokZdOKpicgrCGixbyUuOD4s7KoKraVyw45S1AnGBlU_LSiOBcsIDHgwvO2qp6Sfa6vvMHhBpILfFsKo6CRlwy1bZVUyjJwNs2tCwjbNOb-ueoo6H_yD_AARodkE7FBAfo24wcQK9rs4TRTi--lbjGCmMiIEqVkU_RFVtT5voKGWoN19_PjjWfnp4en89KPcnIh42vNMQNLoaYzvfrG92gsE7FZUboX65QAGcAnhZ1Rl6NXv795pDWoxJhRuro9n_9JH1y8XXWiNf_d9sb8nhkqyAD7i3ZG67X_h1AosG-jz_7L-CJ_SM priority: 102 providerName: Wiley-Blackwell |
Title | Cytokine Dysregulation in Aged Horses and Horses with Pituitary Pars Intermedia Dysfunction |
URI | https://api.istex.fr/ark:/67375/WNG-5HKKGTM2-C/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1939-1676.2008.0076.x https://www.ncbi.nlm.nih.gov/pubmed/18371032 https://search.proquest.com/docview/70451358 https://search.proquest.com/docview/902335214 |
Volume | 22 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwED-x8cILgvGx8DH8gHgLShPbsR8QQoWtW9UJwTom8WA5cTyqoaR0qdT-99ylbrdJG-LF8kN0Se788Tvfz3cAbykpWuJwAibCq5iXPUkkABW7rMp5omzpugO30bEcjPnRmTi7ulkXFHh5q2tH9aTGs9_vF3-WH3HCf7jGytGZjnsyl2tyJPYQWN5PObrrxOfjm9ACQuiQ_lP3Yil5Ekhf_xBEiUXRj6PUczd2ry1vG8S0ZI7FbQD1Jt7tNqz9R_AwIE32aTU0HsO9qt6BnVOiv3R3cNkohNWfwM_-sm0usMvcEl96Hkp6sUnNcLlx7FdDTA9m602Xjm_ZdNLOJy2JmqIOGWWemHU3UUgMbZgk5CmM97-c9AdxqLoQlwLxR5w6pXHH8rKwQpborNrKa-EK5XXGqyzxTlcF4h5fqDwVqZXeOV8gSPfOu6LIsmewXTd1tQvMor9JBasEZTkSKtFliWrUKsEhUPgyiSBZa9NMV8k1zDWnBG1hyBahVCbawiwi2EWtG3uOS6AZf08p8IoLJcJMHcG7zhQbUXZ2QbS1XJgfxwdGDIbDg5NRavoRvFnbyuBkogiJratmfmlyyraTCRUBu-MJjRgHMWuPR_B8ZeWrLw9jJALemf1_f8kcnR6OcvniToEv4cGKpULMt1ew3c7m1WuEQm2xB1sp_4rt58Mhtd_SvW6w_wXX__8h |
link.rule.ids | 315,783,787,1378,2228,11574,24330,27936,27937,46064,46306,46488,46730,50826,50935 |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdgPMALg_GxjI_5AfGWyY1jJ36cOrZsXaoJ2jGJB8uO46qqlKCRSht_PXdJWigaEkK8-aE95ew738_nn-8IeYdF0ZgDB2TCp2FcDCSSANLQ8TKJWWoK1ybc8rHMpvHZlbjq-U_4FqarD7FOuKFntPs1OjgmpDe9XHEVDmQiV5xIGAGefADOz7GNw9HHdSkpQM591U81CKWMWc_16lk9dwnaiFT3vakBv-LU39wFRjexbRucjrfJYqVWx0lZHCwbe1B8_63i4__R-wl53GNYetgZ3VNyr6x2yM4lEmva17007y_sn5Evw9umXsCQHt2CirO-WRidV_RwVjqa1cghoaZaDzExTC_mzXLeoKgLOHjTNm3ZvnFBMRiKUchzMj3-MBlmYd_PISwEIJswcqmCWOilNUIWcAw2pVfC2dQrHpeceadKC4jK2zSJRGSkd85bgP_eeWct5y_IVlVX5S6hBk6y2ApLYP0kkTJVFDwZqJSBcVlfsICw1drpr13ZDv3LcQfmT-P89U04Yf70TUB2YY21mcHmqqefIrzShS0YAKwKyPt24deizPUCCXGJ0J_HJ1pko9HJJI_0MCD7K8vQ4KZ492Kqsl5-0wnW8eEiDQj9wy8UoCdAw4M4IC87m_r55Skox3gUkLi1jL9VSZ9dnuaJ3Pu3v-2Th9kkP9fnp-PRK_KoI8og-e412Wqul-UbQGONfdu62Q86_yP6 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NbxMxELWgSIgLhQLt8lUfELetvB_22scqJU0bEkXQlEocLHu9jkKk3apspLa_npndTSCoSAhx8yEZ7dgz9rP9_IaQdyiKxhwkIONehmkeCSQByNAlRZYyaXLXHLiNxmIwTU8v-EUnKYRvYVp9iPWBG2ZGM19jgl86v5nkKlFhJDKxokRCC-Dkg1QADkZ89GmtJAXAuRP9VFEoRMo6qldH6rnL0MZCdd-bCuAr9vz1XVh0E9o2a1N_m3xbedVSUhYHy9oe5Le_CT7-F7efkMcdgqWHbcg9JfeKcofsnCOtpnnbS0fddf0z8rV3U1cLaNKjG_Bw1pUKo_OSHs4KRwcVMkioKddNPBamk3m9nNdoagLbbtocWjYvXNAMLsRo5DmZ9j-c9QZhV80hzDngmjB2UsFK6IU1XOSwCTaFV9xZ6VWSFgnzThUW8JS3Mot5bIR3zlsA_955Z22SvCBbZVUWe4Qa2MdiISyO6klcMpXnSRYpySC0rM9ZQNhq6PRlK9qhf9nsQP9p7L-uBCf0n74OyB4MsTYzmFr19HOMF7owAQN8VQF534z72pS5WiAdLuP6y_hY88FweHw2inUvIPurwNCQpHjzYsqiWn7XGar4JFwGhP7hFwqwE2DhKA3IbhtSP79cgnMsiQOSNoHxty7p0_OTUSZe_tvf9snDyVFffzwZD1-RRy1LBpl3r8lWfbUs3gAUq-3bJsl-AKGLIqk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cytokine+dysregulation+in+aged+horses+and+horses+with+pituitary+pars+intermedia+dysfunction&rft.jtitle=Journal+of+veterinary+internal+medicine&rft.au=McFarlane%2C+D&rft.au=Holbrook%2C+T+C&rft.date=2008-03-01&rft.issn=0891-6640&rft.volume=22&rft.issue=2&rft.spage=436&rft_id=info:doi/10.1111%2Fj.1939-1676.2008.0076.x&rft_id=info%3Apmid%2F18371032&rft.externalDocID=18371032 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0891-6640&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0891-6640&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0891-6640&client=summon |